Panayotes Demakakos1, Paola Zaninotto, Arie Nouwen. 1. From the Department of Epidemiology and Public Health (P.D., P.Z.), University College London, London, United Kingdom; and Department of Psychology (A.N.), Middlesex University, London, United Kingdom.
Abstract
OBJECTIVE: To examine whether the prospective association between depressive symptoms and glucose metabolism is bidirectional. METHODS: We used a national sample of 4238 community-dwelling individuals 50 years or older from the English Longitudinal Study of Ageing. Participants were categorized into normoglycemic, impaired glucose metabolism (IGM), and undiagnosed and diagnosed diabetes using glycated hemoglobin and self-reported doctor diagnosis. Subthreshold and elevated depressive symptoms were defined by a score between 2 and 3 and 4 or higher, respectively, on the eight-item Center for Epidemiological Studies-Depression scale. RESULTS: In the age-adjusted model, categories of depressive symptoms were associated with incident undiagnosed (odds ratio [OR] = 1.54 [95% confidence interval {CI} = 0.86-2.73] and OR = 1.91 [95% CI = 1.03-3.57] for subthreshold and elevated depressive symptoms, respectively) and diagnosed diabetes (OR = 1.53 [95% CI = 0.80-2.93] and OR = 3.03 [95% CI = 1.66-5.54], respectively) for 6 years of follow-up. The latter association remained significant after adjustment for covariates. Depressive symptoms were not associated with future IGM. Diagnosed diabetes was associated with future elevated depressive symptoms in participants aged 52 to 64 years (OR = 2.17, [95% CI = 1.33-3.56]), but not those 65 years and older (OR = 0.96, [95% CI = 0.59-1.57]) for 4 years of follow-up. Adjustment for covariates partially explained this association. IGM and undiagnosed diabetes were not associated with subsequent elevated depressive symptoms. CONCLUSIONS: These data suggest that there is a bidirectional association between depressive symptoms and diagnosed diabetes in people aged 52 to 64 years but not in people 65 years and older.
OBJECTIVE: To examine whether the prospective association between depressive symptoms and glucose metabolism is bidirectional. METHODS: We used a national sample of 4238 community-dwelling individuals 50 years or older from the English Longitudinal Study of Ageing. Participants were categorized into normoglycemic, impaired glucose metabolism (IGM), and undiagnosed and diagnosed diabetes using glycated hemoglobin and self-reported doctor diagnosis. Subthreshold and elevated depressive symptoms were defined by a score between 2 and 3 and 4 or higher, respectively, on the eight-item Center for Epidemiological Studies-Depression scale. RESULTS: In the age-adjusted model, categories of depressive symptoms were associated with incident undiagnosed (odds ratio [OR] = 1.54 [95% confidence interval {CI} = 0.86-2.73] and OR = 1.91 [95% CI = 1.03-3.57] for subthreshold and elevated depressive symptoms, respectively) and diagnosed diabetes (OR = 1.53 [95% CI = 0.80-2.93] and OR = 3.03 [95% CI = 1.66-5.54], respectively) for 6 years of follow-up. The latter association remained significant after adjustment for covariates. Depressive symptoms were not associated with future IGM. Diagnosed diabetes was associated with future elevated depressive symptoms in participants aged 52 to 64 years (OR = 2.17, [95% CI = 1.33-3.56]), but not those 65 years and older (OR = 0.96, [95% CI = 0.59-1.57]) for 4 years of follow-up. Adjustment for covariates partially explained this association. IGM and undiagnosed diabetes were not associated with subsequent elevated depressive symptoms. CONCLUSIONS: These data suggest that there is a bidirectional association between depressive symptoms and diagnosed diabetes in people aged 52 to 64 years but not in people 65 years and older.
Authors: Carol Kan; Naomi Silva; Sherita Hill Golden; Ulla Rajala; Markku Timonen; Daniel Stahl; Khalida Ismail Journal: Diabetes Care Date: 2013-02 Impact factor: 19.112
Authors: Elizabeth Murray; Eric B Hekler; Gerhard Andersson; Linda M Collins; Aiden Doherty; Chris Hollis; Daniel E Rivera; Robert West; Jeremy C Wyatt Journal: Am J Prev Med Date: 2016-11 Impact factor: 5.043
Authors: Briana Mezuk; Victor Heh; Elizabeth Prom-Wormley; Kenneth S Kendler; Nancy L Pedersen Journal: Psychosom Med Date: 2015-06 Impact factor: 4.312
Authors: Isabella Caroline da Silva Dias; Bruno Carabelli; Daniela Kaori Ishii; Helen de Morais; Milene Cristina de Carvalho; Luiz E Rizzo de Souza; Silvio M Zanata; Marcus Lira Brandão; Thiago Mattar Cunha; Anete Curte Ferraz; Joice Maria Cunha; Janaina Menezes Zanoveli Journal: Mol Neurobiol Date: 2015-12-15 Impact factor: 5.590